Paid Clinical Trials Bellevue
Discover 551 paid clinical trials in Bellevue, Nebraska. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
DupilumabEfficacy and Safety of Subcutaneous Dupilumab for the Treatment of Adult Participants With Chronic Pruritus of Unknown Origin (CPUO) (LIBERTY-CPUO-CHIC)
Sponsor:
Sanofi
Location:
Code:
NCT05263206
Conditions
Pruritus
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Dupilumab
Placebo
Fexofenadine (loratadine if not available)
Moisturizer
SGN-35CA Safety Study of PF-08046044/SGN-35C in Adults With Advanced Cancers
Sponsor:
Seagen, a wholly owned subsidiary of Pfizer
Location:
Code:
NCT06254495
Conditions
Hodgkin Disease
Lymphoma, T-Cell, Peripheral
Lymphoma, Large B-Cell, Diffuse
Lymphoma, Large-Cell, Anaplastic
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
PF-08046044/SGN-35C
LebrikizumabA Study of Lebrikizumab in Adult Participants With Perennial Allergic Rhinitis (PREPARED-1)
Sponsor:
Eli Lilly and Company
Location:
Code:
NCT06339008
Conditions
Perennial Allergic Rhinitis (PAR)
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
LY3650150
Placebo
Standard therapy for INCS
Dara-VCD vs. ChemotherapyComparing Dara-VCD Chemotherapy Plus Stem Cell Transplant to Dara-VCD Chemotherapy Alone for People Who Have Newly Diagnosed AL Amyloidosis
Sponsor:
SWOG Cancer Research Network
Location:
Code:
NCT06022939
Conditions
AL Amyloidosis
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Autologous Hematopoietic Stem Cell Transplantation
Biopsy
Biospecimen Collection
Bone Marrow Aspiration
Bone Marrow Biopsy
Disitamab Vedotin vs ChemotherapyDisitamab Vedotin With Pembrolizumab vs Chemotherapy in Previously Untreated Urothelial Cancer Expressing HER2
Sponsor:
Seagen Inc.
Location:
Code:
NCT05911295
Conditions
Urothelial Carcinoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
disitamab vedotin
pembrolizumab
gemcitabine
cisplatin
carboplatin
Interested in new trials?
Get alerts for new trials in your area by subscribing now
DupilumabStudy Assessing the Long-term Effect of Dupilumab on Prevention of Lung Function Decline in Adult Patients With Uncontrolled Moderate to Severe Asthma
Sponsor:
Sanofi
Location:
Code:
NCT05097287
Conditions
Asthma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Dupilumab
Placebo
Dupilumab & ICS/LABAEfficacy of Dupilumab Added to Medium Dose Inhaled Corticosteroid/Long-acting Beta-agonist (ICS/LABA) in Comparison to ICS Dose Escalation to High Dose ICS/LABA in Adolescent and Adult Patients With Uncontrolled Asthma
Sponsor:
Regeneron Pharmaceuticals
Location:
Code:
NCT06572228
Conditions
Asthma
Eligibility Criteria
Sex: All
Age: 12 - 70+
Healthy Volunteers: Not accepted
Interventions
dupilumab
Matching Placebo
ICS/LABA
1 cm vs. 2 cmMelanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
Sponsor:
Melanoma and Skin Cancer Trials Limited
Location:
Code:
NCT03860883
Conditions
Cutaneous Melanoma, Stage II
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Wide Local Excision = 1cm Margin
Wide Local Excision = 2cm Margin
MyeloMATCHTesting the Effects of Novel Therapeutics for Newly Diagnosed, Untreated Patients With High-Risk Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial)
Sponsor:
National Cancer Institute (NCI)
Location:
Code:
NCT05554406
Conditions
Acute Myeloid Leukemia
Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm
Acute Myeloid Leukemia Post Cytotoxic Therapy
Acute Myeloid Leukemia, Myelodysplasia-Related
Eligibility Criteria
Sex: All
Age: 18 - 59
Healthy Volunteers: Not accepted
Interventions
Azacitidine
Biospecimen Collection
Bone Marrow Aspiration
Cytarabine
Daunorubicin Hydrochloride